Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.
MADRID--(BUSINESS WIRE)--“This is a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system using PFA and Optical Coherence Reflectometry (OCR) to monitor and confirm the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback